ESC 365 - Understanding the benefits of renin-angiotensin-aldosterone system inhibitors and influence of hyperkalaemia on their prescription: a UK survey of healthcare professionals' views and practice

ESC Professional Premium Access

Understanding the benefits of renin-angiotensin-aldosterone system inhibitors and influence of hyperkalaemia on their prescription: a UK survey of healthcare professionals' views and practice

Session: Drugs, devices, and multidisciplinary care in heart failure

Topic: Pharmacotherapy

Speaker: Doctor M. Wasef (Portsmouth, GB)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Mohammad Wasef

Queen Alexandra Hospital, Portsmouth (United Kingdom of Great Britain & Northern Ireland)

0 follower

5 more presentations in this session

Nationwide analysis of in-hospital mortality and renal infarction trends following cardiac output assist device placement from 2017 to 2020

Speaker: Doctor A. Balaji (Brooklyn, US)

Beating the clock: the impact of heart failure duration on CRT efficacy

Speaker: Mr E. Grama (Barcelona, ES)

Optimizing aldosterone receptor antagonist therapy by sodium zirconium cyclosilicate in heart failure - OPRA-HF trial

Speaker: Doctor C. Basic (Gothenburg, SE)

Diuretic dosing and outcomes with torsemide and furosemide following hospitalization for heart failure: the TRANSFORM-HF trial

Speaker: Miss N. Nouhravesh (Durham, US)

Echocardiographic evaluation of cardiac remodelling in a cohort of patients with heart failure and reduced ejection fraction treated with dapagliflozin

Speaker: Doctor J. Bonini (Ferrara, IT)

Access the full session

Drugs, devices, and multidisciplinary care in heart failure

Speakers: Doctor M. Wasef, Doctor A. Balaji, Mr E. Grama, Doctor C. Basic, Miss N. Nouhravesh...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources